Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third editionClare Walton, Peer Baneke, Rachel King et al.|Multiple Sclerosis Journal|2020Cited by 2.5k
Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: A Subgroup Analysis From Three International CohortsSifat Sharmin, Éric Berger, Dana Horáková et al.|CNS Drugs|2021Cited by 12